174 related articles for article (PubMed ID: 35933574)
1. GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH.
Palsgrove DN; Rooper LM; Stevens TM; Shin C; Damm DD; Gagan J; Bridge JA; Thompson LDR; Koduru PR; Bishop JA
Head Neck Pathol; 2022 Dec; 16(4):1146-1156. PubMed ID: 35933574
[TBL] [Abstract][Full Text] [Related]
2. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions.
Agaram NP; Zhang L; Sung YS; Singer S; Stevens T; Prieto-Granada CN; Bishop JA; Wood BA; Swanson D; Dickson BC; Antonescu CR
Mod Pathol; 2019 Nov; 32(11):1617-1626. PubMed ID: 31189998
[TBL] [Abstract][Full Text] [Related]
3. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis.
Xu B; Chang K; Folpe AL; Kao YC; Wey SL; Huang HY; Gill AJ; Rooper L; Bishop JA; Dickson BC; Lee JC; Antonescu CR
Am J Surg Pathol; 2020 Jun; 44(6):729-737. PubMed ID: 31934916
[TBL] [Abstract][Full Text] [Related]
4. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
5. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
6. Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
Machado I; Hosler GA; Traves V; Claramunt R; Sanmartín O; Santonja C; Carvajal N; Zazo S; Requena L; Alfonso VS; Domenech EV; Llombart-Bosch A; Bridge JA; Linos K
J Cutan Pathol; 2023 Jun; 50(6):487-499. PubMed ID: 36316249
[TBL] [Abstract][Full Text] [Related]
7. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
[TBL] [Abstract][Full Text] [Related]
8. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity.
Liu J; Mao R; Lao IW; Yu L; Bai Q; Zhou X; Wang J
Virchows Arch; 2022 May; 480(5):1087-1099. PubMed ID: 34779913
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
10. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
11. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract][Full Text] [Related]
12. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms.
Machado I; Agaimy A; Giner F; Navarro S; Michal M; Bridge J; Claramunt R; López-Guerrero JA; Alcacer J; Linos K; Llombart-Bosch A
Virchows Arch; 2024 May; 484(5):765-775. PubMed ID: 37940743
[TBL] [Abstract][Full Text] [Related]
13. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis.
Kerr DA; Cloutier JM; Margolis M; Mata DA; Rodrigues Simoes NJ; Faquin WC; Dias-Santagata D; Chopra S; Charville GW; Wangsiricharoen S; Lazar AJ; Wang WL; Rosenberg AE; Tse JY
Mod Pathol; 2024 Feb; 37(2):100386. PubMed ID: 37992966
[TBL] [Abstract][Full Text] [Related]
14. Unique case of a
Godse NR; Alsulaimani S; Singh AD; Fletcher CD; Astbury C; Fritchie K; Recinos PF; Sindwani R
Orbit; 2023 Jun; ():1-5. PubMed ID: 37345250
[No Abstract] [Full Text] [Related]
15. Expression of CTAG1B clone EPR13780 versus
Abdelaziz MM; Tayel HY; Abdel-Bary A; Badawy OM
J Histotechnol; 2022 Jun; 45(2):56-65. PubMed ID: 34845972
[TBL] [Abstract][Full Text] [Related]
16. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
17. Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.
Lavernia J; Claramunt R; Romero I; López-Guerrero JA; Llombart-Bosch A; Machado I
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275873
[TBL] [Abstract][Full Text] [Related]
18. Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.
Bishop JA; Rooper LM; Chiosea SI; Westra WH
Am J Surg Pathol; 2018 Mar; 42(3):367-371. PubMed ID: 29076874
[TBL] [Abstract][Full Text] [Related]
19. GLI1-altered epithelioid soft tissue tumor: A newly described entity with a predilection for the tongue.
Zhong H; Xu C; Chen X; Guo X; Yang S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jul; 134(1):e14-e22. PubMed ID: 35165054
[TBL] [Abstract][Full Text] [Related]
20. A cryptic EWSR1::DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics.
Ibstedt S; de Mattos CBR; Köster J; Mertens F
Genes Chromosomes Cancer; 2023 Mar; 62(3):167-170. PubMed ID: 36379683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]